Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Kandace L. Amend, Bruce Turnbull, Li Zhou, Morgan A. Marks, Christine Velicer, Patricia Saddier & John D. Seeger. (2022) Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Abbey B. Berenson, Richard Rupp, Erin E. Dinehart, Leslie E. Cofie, Yong-Fang Kuo & Jacqueline M. Hirth. (2019) Achieving high HPV vaccine completion rates in a pediatric clinic population. Human Vaccines & Immunotherapeutics 15:7-8, pages 1562-1569.
Read now
Read now
Maria Rosaria Gualano, Robin Thomas, Michela Stillo, Maria Valentina Mussa, Francesca Quattrocolo, Alberto Borraccino & Carla Zotti. (2019) What is the most useful tool in HPV vaccine promotion? Results from an experimental study. Human Vaccines & Immunotherapeutics 15:7-8, pages 1607-1614.
Read now
Read now
Tina Hovgaard Lützen, Bodil Hammer Bech, Jesper Mehlsen, Claus Høstrup Vestergaard, Lene Wulff Krogsgaard, Jørn Olsen, Mogens Vestergaard, Oleguer Plana-Ripoll & Dorte Rytter. (2017) Psychiatric conditions and general practitioner attendance prior to HPV vaccination and the risk of referral to a specialized hospital setting because of suspected adverse events following HPV vaccination: a register-based, matched case–control study. Clinical Epidemiology 9, pages 465-473.
Read now
Read now
Pier Luigi Lopalco. (2017) Spotlight on the 9-valent HPV vaccine. Drug Design, Development and Therapy 11, pages 35-44.
Read now
Read now
Hannah Priest Catalano, Adam P. Knowlden, David A. Birch, James D. Leeper, Angelia M. Paschal & Stuart L. Usdan. (2017) Using the Theory of Planned Behavior to predict HPV vaccination intentions of college men. Journal of American College Health 65:3, pages 197-207.
Read now
Read now
Samara Perez, Claire Fedoruk, Gilla K. Shapiro & Zeev Rosberger. (2016) Giving Boys a Shot: The HPV Vaccine’s Portrayal in Canadian Newspapers. Health Communication 31:12, pages 1527-1538.
Read now
Read now
Robert M. Jacobson, Amenah A. Agunwamba, Jennifer L. St. Sauver & Lila J. Finney Rutten. (2016) The most effective and promising population health strategies to advance human papillomavirus vaccination. Expert Review of Vaccines 15:2, pages 257-269.
Read now
Read now
Britain Baker, Luísa Eça Guimarães, Lucija Tomljenovic, Nancy Agmon-Levin & Yehuda Shoenfeld. (2015) The safety of human papilloma virus-blockers and the risk of triggering autoimmune diseases. Expert Opinion on Drug Safety 14:9, pages 1387-1394.
Read now
Read now
Articles from other publishers (44)
Ross Shegog, Lara S. Savas, Erica L. Frost, Laura C. Thormaehlen, Travis Teague, Jack Steffy, Catherine Mary Healy, Laura Aubree Shay, Sharice Preston & Sally W. Vernon. (2023) Adaptation and Formative Evaluation of Online Decision Support to Implement Evidence-Based Strategies to Increase HPV Vaccination Rates in Pediatric Clinics. Vaccines 11:7, pages 1270.
Crossref
Crossref
Asmaa Gohar, Aya A. Ali, Walid F. Elkhatib, Gharieb S. El-Sayyad, Dounia Elfadil & Ayman M. Noreddin. (2022) Combination therapy between prophylactic and therapeutic human papillomavirus (HPV) vaccines with special emphasis on implementation of nanotechnology. Microbial Pathogenesis 171, pages 105747.
Crossref
Crossref
Antonio Di Lorenzo, Paola Berardi, Andrea Martinelli, Francesco Paolo Bianchi, Silvio Tafuri & Pasquale Stefanizzi. (2022) Real-Life Safety Profile of the 9-Valent HPV Vaccine Based on Data from the Puglia Region of Southern Italy. Vaccines 10:3, pages 419.
Crossref
Crossref
Srikanth Umakanthan, Sonal Patil, Naveen Subramaniam & Ria Sharma. (2021) COVID-19 Vaccine Hesitancy and Resistance in India Explored through a Population-Based Longitudinal Survey. Vaccines 9:10, pages 1064.
Crossref
Crossref
Noelia López, Maria Garcés-Sánchez, Maria Belén Panizo, Ignacio Salamanca de la Cueva, Maria Teresa Artés, Beatriz Ramos & Manuel Cotarelo. (2020) HPV knowledge and vaccine acceptance among European adolescents and their parents: a systematic literature review. Public Health Reviews 41:1.
Crossref
Crossref
Rosella Franconi, Silvia Massa, Francesca Paolini, Patrizia Vici & Aldo Venuti. (2020) Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers. Cancers 12:11, pages 3101.
Crossref
Crossref
Wandee Chanprasertpinyo & Chaiwat Rerkswattavorn. (2020) Human papillomavirus (HPV) vaccine status and knowledge of students at a university in rural Thailand. Heliyon 6:8, pages e04625.
Crossref
Crossref
Jason M. Bodily, Ikuo Tsunoda & J. Steven Alexander. (2020) Scientific Evaluation of the Court Evidence Submitted to the 2019 Human Papillomavirus Vaccine Libel Case and Its Decision in Japan. Frontiers in Medicine 7.
Crossref
Crossref
Cristina Giambi & Giovanni Rezza. 2020. Sexually Transmitted Infections. Sexually Transmitted Infections
375
389
.
Jung Ran, Ji-Young Yang, Ji-Ho Lee, Hye-Jun Kim, Jun-Yeong Choi & Ju-Young Shin. (2019) Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016. International Journal of Clinical Pharmacy 41:5, pages 1365-1372.
Crossref
Crossref
Cristhian PreciadoPaolo Vallejo Janeta. (2019) Situation of Human Papilloma Virus: Generalities and current treatments. Bionatura 02:Bionatura Conference Serie.
Crossref
Crossref
Janvier Rwamwejo, Silvina Ramos, Karen Morgan, Karin Richter, Chan Joo Kim, Mercè Peris & Jennifer S Smith. (2019) Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study. International Journal of Gynecologic Cancer 29:2, pages 250-256.
Crossref
Crossref
Alistair Wardrope & Markus Reuber. (2019) Medicine and the media: the ethics of virtual medical encounters. Clinical Medicine 19:1, pages 11-15.
Crossref
Crossref
Stephen Joel Coons & Mira J. Patel. 2019. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention
17
29
.
Tiffany A. Suragh, Paige Lewis, Jorge Arana, Adamma Mba-Jonas, Rongxia Li, Brock Stewart, Tom T. Shimabukuro & Maria Cano. (2018) Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017. British Journal of Clinical Pharmacology 84:12, pages 2928-2932.
Crossref
Crossref
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal & Wanpen Chaicumpa. (2018) Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Frontiers in Immunology 9.
Crossref
Crossref
Paolo Bonanni, Beatrice Zanella, Francesca Santomauro, Chiara Lorini, Angela Bechini & Sara Boccalini. (2018) Safety and perception: What are the greatest enemies of HPV vaccination programmes?. Vaccine 36:36, pages 5424-5429.
Crossref
Crossref
Abdul Nazer Ali, Ng Yen Ping, Sunil K Prajapati, Lim Cheng Pheng, Mohd Zahid Iqbal & Nazer Zulfikar Ahmed. (2018) Effect of intervention in increasing knowledge and awareness of Human Papilloma Virus (HPV) infection and HPV vaccination among graduate students in a private university, Kedah state, Malaysia. MOJ Bioequivalence & Bioavailability 5:4.
Crossref
Crossref
Ryota Hikiami, Hodaka Yamakado, Shinsui Tatsumi, Takashi Ayaki, Yuichiro Hashi, Hirofumi Yamashita, Nobukatsu Sawamoto, Teruyuki Tsuji, Makoto Urushitani & Ryosuke Takahashi. (2018) Amyotrophic Lateral Sclerosis after Receiving the Human Papilloma Virus Vaccine: A Case Report of a 15-year-old Girl. Internal Medicine 57:13, pages 1917-1919.
Crossref
Crossref
W Katherine Yih, Judith C Maro, Michael Nguyen, Meghan A Baker, Carolyn Balsbaugh, David V Cole, Inna Dashevsky, Adamma Mba-Jonas & Martin Kulldorff. (2018) Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System. American Journal of Epidemiology 187:6, pages 1269-1276.
Crossref
Crossref
Sadao Suzuki & Akihiro Hosono. (2018) No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study. Papillomavirus Research 5, pages 96-103.
Crossref
Crossref
Aaron M. Scherer, Heather Schacht Reisinger, Marin L. Schweizer, Natoshia M. Askelson, Angela Fagerlin & Charles F. Lynch. (2018) Cross-sectional associations between psychological traits, and HPV vaccine uptake and intentions in young adults from the United States. PLOS ONE 13:2, pages e0193363.
Crossref
Crossref
A. Hviid, H. Svanström, N. M. Scheller, O. Grönlund, B. Pasternak & L. Arnheim-Dahlström. (2018) Human papillomavirus vaccination of adult women and risk of autoimmune and neurological diseases. Journal of Internal Medicine 283:2, pages 154-165.
Crossref
Crossref
Tetsuo Nakayama, Yasuyo Kashiwagi & Hisashi Kawashima. (2018) Long-term regulation of local cytokine production following immunization in mice. Microbiology and Immunology 62:2, pages 124-131.
Crossref
Crossref
Julia M.L. Brotherton & Paul N. Bloem. (2018) Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage. Best Practice & Research Clinical Obstetrics & Gynaecology 47, pages 42-58.
Crossref
Crossref
Lene Wulff Krogsgaard, Claus Høstrup Vestergaard, Oleguer Plana-Ripoll, Tina Hovgaard Lützen, Mogens Vestergaard, Morten Fenger-Grøn, Bodil Hammer Bech & Dorte Rytter. (2017) Health care utilization in general practice after HPV vaccination—A Danish nationwide register-based cohort study. PLOS ONE 12:9, pages e0184658.
Crossref
Crossref
Hyoung Jin Kim & Hong-Jin Kim. (2017) Current status and future prospects for human papillomavirus vaccines. Archives of Pharmacal Research 40:9, pages 1050-1063.
Crossref
Crossref
Berit Feiring, Ida Laake, Inger Johanne Bakken, Margrethe Greve-Isdahl, Vegard Bruun Wyller, Siri E. Håberg, Per Magnus & Lill Trogstad. (2017) HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine 35:33, pages 4203-4212.
Crossref
Crossref
O. Grönlund, E. Herweijer, K. Sundström & L. Arnheim‐Dahlström. (2016)
Authors’ response: Letter to the Editor –
HPV
vaccine and autoimmunity
. Journal of Internal Medicine 281:3, pages 311-312.
Crossref
Crossref
Haruko Tashiro & Malcolm K Brenner. (2016) Immunotherapy against cancer-related viruses. Cell Research 27:1, pages 59-73.
Crossref
Crossref
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenWilliam Bonnez. 2016. Clinical Virology. Clinical Virology
625
678
.
Samara Perez, Ovidiu Tatar, Gilla K. Shapiro, Eve Dubé, Gina Ogilvie, Juliet Guichon, Vladimir Gilca & Zeev Rosberger. (2016) Psychosocial determinants of parental human papillomavirus (HPV) vaccine decision-making for sons: Methodological challenges and initial results of a pan-Canadian longitudinal study. BMC Public Health 16:1.
Crossref
Crossref
O. Grönlund, E. Herweijer, K. Sundström & L. Arnheim-Dahlström. (2016) Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study. Journal of Internal Medicine 280:6, pages 618-626.
Crossref
Crossref
Laurent Abramowitz, Philippe Descamps, François Denis, Marie-Aliette Dommergues, Pierre Pradat, Jean Lacau St Guily & Philippe Judlin. (2016) Papillomavirus and cancers: should we extend vaccination to boys in France?. Journal of Public Health.
Crossref
Crossref
Alice S. Forster & Jo Waller. (2016) Taking stock and looking ahead: Behavioural science lessons for implementing the nonavalent human papillomavirus vaccine. European Journal of Cancer 62, pages 96-102.
Crossref
Crossref
Roberto Angioli, Salvatore Lopez, Alessia Aloisi, Corrado Terranova, Carlo De Cicco, Giuseppe Scaletta, Stella Capriglione, Andrea Miranda, Daniela Luvero, Roberto Ricciardi, Roberto Montera & Francesco Plotti. (2016) Ten years of HPV vaccines: State of art and controversies. Critical Reviews in Oncology/Hematology 102, pages 65-72.
Crossref
Crossref
Carolee Polek, Heather Bittner Fagan, Mary Stephens, Marth Aoppage-Lawrence & Thomas Hardie. (2016) Declining HPV Vaccination Rates in Delaware: Cause for Concern and Action. Delaware Journal of Public Health 2:2, pages 36-40.
Crossref
Crossref
Mariam El-Zein, Lyndsay Richardson & Eduardo L. Franco. (2016) Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none. Journal of Clinical Virology 76, pages S62-S68.
Crossref
Crossref
F. Xavier Bosch, Claudia Robles, Mireia Díaz, Marc Arbyn, Iacopo Baussano, Christine Clavel, Guglielmo Ronco, Joakim Dillner, Matti Lehtinen, Karl-Ulrich Petry, Mario Poljak, Susanne K. Kjaer, Chris J. L. M. Meijer, Suzanne M. Garland, Jorge Salmerón, Xavier Castellsagué, Laia Bruni, Silvia de Sanjosé & Jack Cuzick. (2015) HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nature Reviews Clinical Oncology 13:2, pages 119-132.
Crossref
Crossref
José Tuells. (2016) Controversias sobre vacunas en España, una oportunidad para la vacunología social. Gaceta Sanitaria 30:1, pages 1-3.
Crossref
Crossref
K.M. Damer & C.M. Jung. 2016. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
307
334
.
Amira H. Bakir & Martin Skarzynski. (2015) Health Disparities in the Immunoprevention of Human Papillomavirus Infection and Associated Malignancies. Frontiers in Public Health 3.
Crossref
Crossref
Samara Perez, Gilla K. Shapiro, Christopher A. Brown, Eve Dube, Gina Ogilvie & Zeev Rosberger. (2015) ‘I didn't even know boys could get the vaccine’: Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons. Psycho-Oncology 24:10, pages 1316-1323.
Crossref
Crossref
C. Moreman, C. W. E. Redman & E. L. Moss. (2015) Human Papillomavirus and Its Role in Cervical Cancer Screening and Treatment. Current Treatment Options in Infectious Diseases 7:3, pages 217-229.
Crossref
Crossref